{
  "columnHierarchy": {
    "epochs": [
      {
        "id": "epoch_1",
        "name": "Pre-Treatment",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "f4aa5e9f-a6da-4ec1-8818-236fc22856db",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      },
      {
        "id": "epoch_2",
        "name": "During Treatment",
        "instanceType": "StudyEpoch",
        "type": {
          "id": "d3bf21b8-4c06-4636-9dd8-bb5d2af22efe",
          "code": "C98780",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment Epoch",
          "instanceType": "Code"
        }
      }
    ],
    "encounters": [
      {
        "id": "enc_1",
        "name": "Baseline",
        "instanceType": "Encounter",
        "type": {
          "id": "9f5f64a1-2713-4ea6-91c8-3fe9753f2b0b",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_1"
      },
      {
        "id": "enc_2",
        "name": "Cycle 1 - Day 1",
        "instanceType": "Encounter",
        "type": {
          "id": "686bdd43-e9fe-48e2-882f-467a26a22918",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      },
      {
        "id": "enc_3",
        "name": "Cycle 2 - Day 1 (and every cycle thereafter)",
        "instanceType": "Encounter",
        "type": {
          "id": "56230c7c-4424-4429-a749-a716c2a4f62b",
          "code": "C82517",
          "codeSystem": "http://www.cdisc.org",
          "codeSystemVersion": "2024-09-27",
          "decode": "Baseline",
          "instanceType": "Code"
        },
        "epochId": "epoch_2"
      }
    ],
    "plannedTimepoints": [
      {
        "id": "pt_1",
        "visit": "Baseline",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_1",
        "instanceType": "Timing"
      },
      {
        "id": "pt_2",
        "visit": "C1D1",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_2",
        "instanceType": "Timing"
      },
      {
        "id": "pt_3",
        "visit": "C2D1+",
        "epoch": "",
        "epochId": "",
        "day": "",
        "window": null,
        "encounterId": "enc_3",
        "instanceType": "Timing"
      }
    ]
  },
  "rowGroups": [
    {
      "id": "grp_1",
      "name": "Eligibility Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Informed Consent",
        "Inclusion/Exclusion Criteria",
        "Medical History",
        "Child-Pugh Score"
      ]
    },
    {
      "id": "grp_2",
      "name": "Safety Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Physical examination",
        "Physical Measurements",
        "ECOG Assessment",
        "Vital Signs",
        "Assessment of Signs and Symptoms",
        "Concomitant Medication Collection",
        "12 lead ECG",
        "2D Echocardiogram",
        "Laboratory Tests",
        "Targeted Physical examination",
        "Adverse Events Assessment",
        "Review of Concomitant Medication",
        "Pregnancy test (WOCBP only)",
        "Coagulation profile"
      ]
    },
    {
      "id": "grp_3",
      "name": "Outcomes Research Assessment",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "EQ-5D-3L",
        "FACT-Hep",
        "Health care resource use (HCRU)"
      ]
    },
    {
      "id": "grp_4",
      "name": "Clinical Drug Supplies",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Contact central randomization IVRS / Dispense Study Drug"
      ]
    },
    {
      "id": "grp_5",
      "name": "Efficacy Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Tumor imaging assessment"
      ]
    },
    {
      "id": "grp_6",
      "name": "Other Assessments",
      "description": null,
      "childIds": [],
      "instanceType": "Activity",
      "activityNames": [
        "Serum sample (soluble factors)",
        "Peripheral blood mononuclear cells (PBMCs) and myeloid derived suppressor cells (MDSCs)"
      ]
    }
  ],
  "footnotes": [
    "Original informed consent in screening for protocol participation.",
    "Assessed during screening period and (re-enrollment if applicable).",
    "Within 14 days prior to first dose.",
    "Height and Weight. Within 14 days prior to first dose.",
    "Including BP, HR, temperature, respiratory rate. Obtain vital signs at the screening visit and within 72 hours prior to first dose.",
    "2-D echocardiogram, performed locally, for valve and LVEF evaluation is to be done within 14 days prior to first dose and as clinically indicated.",
    "Performed locally, within 14 days prior to randomization to include CBC w/differential and platelet count, LFTs (ALT, AST, total bilirubin, alkaline phosphatase), Alpha fetoprotein (AFP), BUN or serum urea level, albumin, creatinine, Ca+, Mg++, Na+, K+, Cl-, LDH, amylase, lipase, Glucose, TSH, Free T4, Free T3",
    "Targeted examination must include at a minimum the following body systems: Cardiovascular, Gastrointestinal, Pulmonary, Skin",
    "Serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) to be done within 24 hours prior to first dose, and then monthly regardless of dosing schedule"
  ]
}